| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 51.818 | 32.305 | 106.676 | 423.666 | 195.612 | 122.743 |
| Total Income - EUR | - | - | - | - | 51.844 | 35.002 | 116.605 | 432.974 | 211.371 | 139.771 |
| Total Expenses - EUR | - | - | - | - | 18.629 | 32.838 | 53.192 | 109.227 | 137.347 | 127.186 |
| Gross Profit/Loss - EUR | - | - | - | - | 33.215 | 2.164 | 63.413 | 323.747 | 74.024 | 12.585 |
| Net Profit/Loss - EUR | - | - | - | - | 32.797 | 1.841 | 62.346 | 319.741 | 72.647 | 10.126 |
| Employees | - | - | - | - | 2 | 3 | 2 | 4 | 2 | 1 |
Check the financial reports for the company - All Biopsy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 24.554 | 20.403 | 10.385 | 8.496 | 16.310 | 29.487 |
| Current Assets | - | - | - | - | 71.938 | 75.163 | 137.930 | 462.610 | 491.544 | 82.571 |
| Inventories | - | - | - | - | 0 | 2.549 | 0 | 6.379 | 6.233 | 1.275 |
| Receivables | - | - | - | - | 71.114 | 72.603 | 136.293 | 456.247 | 471.166 | 77.735 |
| Cash | - | - | - | - | 824 | 11 | 1.637 | -17 | 14.145 | 3.562 |
| Shareholders Funds | - | - | - | - | 32.839 | 34.058 | 95.649 | 415.686 | 426.424 | 10.166 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 26.118 | 24.685 | 24.139 | 26.803 | 61.190 | 96.986 |
| Income in Advance | - | - | - | - | 37.535 | 36.824 | 28.527 | 28.616 | 20.240 | 4.906 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - All Biopsy S.r.l.